Quantifying cathepsin S activity in antigen presenting cells using a novel specific substrate.
about
Assessing protein immunogenicity with a dendritic cell line-derived endolysosomal degradomeProtease recognition sites in Bet v 1a are cryptic, explaining its slow processing relevant to its allergenicity.The influence of linker length on the properties of cathepsin S cleavable (177)Lu-labeled HPMA copolymers for pancreatic cancer imagingHighly sensitive and adaptable fluorescence-quenched pair discloses the substrate specificity profiles in diverse protease families.177Lu-labeled HPMA copolymers utilizing cathepsin B and S cleavable linkers: synthesis, characterization and preliminary in vivo investigation in a pancreatic cancer model.HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phaseTargeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation.Protease-activated receptors and itch.The liberation of fractalkine in the dorsal horn requires microglial cathepsin S.Protective cellular immunity generated by cross-presenting recombinant overlapping peptide proteins.Plasminogen hydrolysis by cathepsin S and identification of derived peptides as selective substrate for cathepsin V and cathepsin L inhibitor.Investigation into the Biological Impact of Block Size on Cathepsin S-Degradable HPMA Copolymers.Retinoic acid prevents immunogenicity of milk lipocalin Bos d 5 through binding to its immunodominant T-cell epitope.Eliciting unnatural immune responses by activating cryptic epitopes in viral antigens.
P2860
Q28742682-283312D6-52CB-4CCE-9DFC-CF1D28AA8945Q30405313-AF9012C6-3F4E-4EDE-BC07-2DA5B38CE9D3Q33981400-78FF44DD-956C-453A-A86C-EB5D04CEC845Q36288119-7A54EFD7-0C01-44A0-BF73-95622B54F734Q36881050-41F71E8B-5D1A-46F0-8143-B0CAFF552B24Q37262510-9202B6F3-1C2E-46CE-8F5B-1166504737AAQ37363754-BC828121-9A6F-4E25-909F-BF182954D7B1Q38415128-C22DB739-08CD-4C07-ACC6-7126F9385CCBQ41375167-CFBBE20E-0881-4A92-B1AA-56A3992FF154Q42938763-5C810FA6-AA5A-4035-9A05-3507986EDC04Q43123729-08E60073-4A36-497B-862A-4AF6F852B467Q47231065-9BEEC1B6-DD90-48B1-AEF6-3FB39BF597D7Q48043750-D82B3BC9-4F37-4AEB-9092-A75735489315Q52344693-FD513598-6DB7-490B-8BCB-2EA115522D2A
P2860
Quantifying cathepsin S activity in antigen presenting cells using a novel specific substrate.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Quantifying cathepsin S activi ...... ng a novel specific substrate.
@en
type
label
Quantifying cathepsin S activi ...... ng a novel specific substrate.
@en
prefLabel
Quantifying cathepsin S activi ...... ng a novel specific substrate.
@en
P2860
P356
P1476
Quantifying cathepsin S activi ...... ng a novel specific substrate.
@en
P2093
Hubert Kalbacher
Nicolas Lützner
P2860
P304
36185-36194
P356
10.1074/JBC.M806500200
P407
P577
2008-10-28T00:00:00Z